Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis

Area of Science:

• Neuroscience
• Otolaryngology
• Pharmacology

Background:

• Sensorineural hearing loss is a frequent complication of pneumococcal meningitis.
• Corticosteroids may mitigate hearing loss by reducing inflammation, but research findings are conflicting.
• The study aimed to clarify the role of systemic steroids in preventing hearing loss and cochlear damage in a rat model.

Purpose of the Study:

• To investigate the efficacy of systemic steroid treatment in reducing hearing loss and cochlear damage in a rat model of pneumococcal meningitis.
• To assess the impact of steroids on auditory function and neuronal survival post-meningitis.

Main Methods:

• A controlled animal study involving adult rats with experimentally induced pneumococcal meningitis.
• Rats were randomly assigned to receive systemic steroid or saline treatment for three days.
• Hearing loss and cochlear damage were evaluated using distortion product otoacoustic emissions (DPOAE), auditory brainstem response (ABR), and spiral ganglion neuron density.

Main Results:

• Steroid treatment significantly reduced hearing loss as measured by DPOAE (P < .05).
• A trend towards reduced spiral ganglion neuron loss was observed (P = .0513).
• Pooled data confirmed a significant reduction in spiral ganglion neuron loss with steroid treatment (P = .0098).

Conclusions:

• Systemic steroid administration effectively reduces long-term hearing loss in experimental pneumococcal meningitis.
• Steroids also protect spiral ganglion neurons, crucial for auditory function.
• These findings support the use of anti-inflammatory agents to prevent hearing impairment and cochlear damage in meningitis.